Cavanaugh Sarah's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Aug 19, 2022
- Accession no.
- 0001415889-22-008896
- Filed
- Aug 19, 2022
- Trade date
- Aug 17-18, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.20M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cavanaugh SarahCIK 0001709113 | Officer (SVP OF CORP AFFAIRS & ADMIN.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | MOption exerciseAcquired | +31,312 | $2.78 | +$87,047.36 | 32,596 | Direct | |
| Aug 17, 2022 | Common Stock | SSaleDisposed | −31,312 | $36.73 | −$1,150,089.76 | 1,284 | Direct | |
| Aug 18, 2022 | Common Stock | MOption exerciseAcquired | +1,355 | $9.02 | +$12,222.1 | 2,639 | Direct | |
| Aug 18, 2022 | Common Stock | SSaleDisposed | −1,355 | $36.38 | −$49,294.9 | 1,284 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Common Stock | MOption exerciseDisposed | −31,312 | $0.00 | $0 | 10,750 | Direct | |
| Aug 18, 2022 | Common Stock | MOption exerciseDisposed | −1,355 | $0.00 | $0 | 10,103 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.